{"product_id":"levoreact-ofta-collirio-0-5mg-ml-flacone-4ml-acquista-online-su-farmaclick","title":"Levoreact Ofta Eye Drops 0.5mg\/ml 4ml Bottle | Buy Online at Farmaclick","description":"\u003ch2\u003eLevoreact Ofta Eye Drops 0.5mg\/ml 4ml Bottle\u003c\/h2\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003ePHARMACOTHERAPEUTIC CATEGORY:\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eAntihistamines for local use.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eACTIVE INGREDIENTS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eOne ml of eye drops, suspension contains: levocabastine hydrochloride 0.54 mg (equivalent to 0.5 mg of levocabastine).\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eEXCIPIENTS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003ePropylene glycol, sodium dihydrogen phosphate monohydrate, anhydrous disodium hydrogen phosphate, hydroxypropylmethylcellulose 2910, polysorbate 80, benzalkonium chloride, disodium edetate, water for injections.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eINDICATIONS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eAllergic conjunctivitis.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eCONTRAINDICATIONS\/SIDE EFFECTS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eHypersensitivity to the active substance or to any of the excipients.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eDOSAGE:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eAdults and children: the usual dose is 1 drop per eye, 2 times a day.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eThe dose can be increased to 1 drop up to 3 or 4 times a day.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eTreatment should be continued for the period necessary for the disappearance of symptoms.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eMethod of administration: ophthalmic use.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eSTORAGE:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eDo not store above 25 degrees C.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eWARNINGS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eAs with all ophthalmic preparations containing benzalkonium chloride, propylene glycol and esters, patients should be informed not to wear soft (hydrophilic) contact lenses during treatment with the eye drops suspension because they may cause ocular irritation.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eRemove contact lenses before applying the medicine and wait at least 15 minutes before putting them back in.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eThe medicine discolors soft contact lenses.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eINTERACTIONS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eNo interaction studies have been performed.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003eUNDESIRABLE EFFECTS:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eAdverse reaction frequency: very common \u0026gt;=1\/10, common \u0026gt;=1\/100 and \u0026lt;1\/10, uncommon \u0026gt;=1\/1000 and \u0026lt;1\/100, rare \u0026gt;=1\/10,000 and \u0026lt;1\/1000, very rare \u0026lt;1\/10,000, not known.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eCardiac disorders.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eNot known: palpitations.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eEye disorders.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eCommon: eye pain, blurred vision; uncommon: eyelid edema; not known: conjunctivitis, eye swelling, blepharitis, ocular hyperemia.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eGeneral disorders and administration site conditions.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eCommon: application site reaction, including burning\/stinging sensation in the eyes, ocular irritation; very rare: application site reaction, such as eye redness, eye pruritus; not known: application site reaction, such as lacrimation.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eImmune system disorders.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eNot known: angioedema, hypersensitivity, anaphylactic reaction.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eSkin and subcutaneous tissue disorders.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eNot known: contact dermatitis, urticaria.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eNervous system disorders.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eCommon: headache.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eReport any suspected adverse reactions via the national reporting system.\u003c\/span\u003e\u003c\/p\u003e\u003cp\u003e\u003cspan style=\"font-size: medium;\"\u003ePREGNANCY AND BREASTFEEDING:\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eStudies conducted in animals have not shown embryotoxic or teratogenic effects.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003ePost-marketing data regarding the use of levocabastine eye drops, suspension in pregnant women are limited; the risk to humans is unknown, therefore it should not be used during pregnancy, unless the potential benefit to the woman justifies the potential fetal risk.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eBased on determinations of levocabastine concentration in saliva and breast milk of a breastfeeding woman who was administered a single oral dose of 0.5 mg of levocabastine, it is expected that approximately 0.3% of the total dose of ophthalmologically administered levocabastine may be passed to the infant.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eHowever, due to the limited availability of clinical and experimental data, caution is recommended when administering the drug to breastfeeding women.\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: medium;\"\u003eAnimal data have shown no effects on male or female fertility.\u003c\/span\u003e\u003c\/p\u003e","brand":"SalusMarket Salute e Benessere Online","offers":[{"title":"Default Title","offer_id":53458774425942,"sku":"27699026","price":7.97,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0968\/4507\/0678\/files\/Levoreact-Ofta-Collirio-0_2C5mgml-Flacone-4ml.webp?v=1778216970","url":"https:\/\/farmasmart.shop\/en\/products\/levoreact-ofta-collirio-0-5mg-ml-flacone-4ml-acquista-online-su-farmaclick","provider":"SalusMarket Salute e Benessere Online","version":"1.0","type":"link"}